ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Kiniksa Pharmaceuticals International PLC

Kiniksa Pharmaceuticals International PLC (KNSA)

21.61
0.40
(1.89%)
At close: July 15 4:00PM
21.61
-0.03
( -0.14% )
After Hours: 4:25PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
21.61
Bid
21.07
Ask
23.00
Volume
383,558
21.22 Day's Range 21.86
14.12 52 Week Range 22.12
Market Cap
Previous Close
21.21
Open
21.35
Last Trade Time
16:53:02
Financial Volume
$ 8,253,830
VWAP
21.5191
Average Volume (3m)
396,905
Shares Outstanding
70,940,145
Dividend Yield
-
PE Ratio
109.02
Earnings Per Share (EPS)
0.2
Revenue
270.26M
Net Profit
14.08M

About Kiniksa Pharmaceuticals International PLC

Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its clinical-stage product candidates include Rilonacept, for the treatment of recurre... Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its clinical-stage product candidates include Rilonacept, for the treatment of recurrent pericarditis, a debilitating inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody for the treatment of giant cell arteritis; Vixarelimab; and KPL-404. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
London, Gbr
Founded
1970
Kiniksa Pharmaceuticals International PLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker KNSA. The last closing price for Kiniksa Pharmaceuticals was $21.21. Over the last year, Kiniksa Pharmaceuticals shares have traded in a share price range of $ 14.12 to $ 22.12.

Kiniksa Pharmaceuticals currently has 70,940,145 shares outstanding. The market capitalization of Kiniksa Pharmaceuticals is $1.50 billion. Kiniksa Pharmaceuticals has a price to earnings ratio (PE ratio) of 109.02.

KNSA Latest News

Kiniksa Pharmaceuticals Commences Enrollment in Abiprubart Phase 2b Clinical Trial in Sjögren’s Disease

– Abiprubart Phase 2b clinical trial in Sjögren’s Disease to evaluate treatment response across biweekly and monthly subcutaneous administrations – – Abiprubart clinical development in Sjögren’s...

Kiniksa Pharmaceuticals Partners with NHL Hall-of-Famer Henrik Lundqvist to Raise Awareness of Recurrent Pericarditis

– Campaign to elevate experiences from the recurrent pericarditis community and provide resources to patients and caregivers – HAMILTON, Bermuda, June 24, 2024 (GLOBE NEWSWIRE) -- Kiniksa...

Kiniksa Pharmaceuticals Sponsors American Heart Association’s Addressing Recurrent Pericarditis Initiative

– Initiative aimed at improving access and outcomes for patients with recurrent pericarditis – – American Heart Association to work with champions at 15 healthcare sites to implement initiative...

Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference

HAMILTON, Bermuda, June 04, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the Goldman Sachs 45th...

Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference

HAMILTON, Bermuda, May 07, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the Bank of America...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
12.0110.255102040819.622.1219.3850459820.81784423CS
42.8815.376401494918.7322.1217.3854094519.16269324CS
124.5126.374269005817.122.1216.8739690519.10858165CS
262.9215.623327982918.6922.1216.5637398519.25345773CS
52747.912388774814.6122.1214.1242717418.2321351CS
1568.1560.549777117413.4622.127.3639226714.57669364CS
2607.755.355859094213.91335.0136612815.48543708CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WNWMeiwu Technology Company Ltd
$ 1.28
(43.82%)
3.87M
SVRESaverOne 2014 Ltd
$ 0.54
(21.59%)
3M
SISIShineco Inc
$ 1.16
(18.37%)
904.97k
SIEBSiebert Financial Corporation
$ 1.97
(14.53%)
7.29k
ETONEton Pharmaceuticals Inc
$ 3.69
(10.48%)
222.69k
CYNCYNGN Inc
$ 7.83
(-14.71%)
144.78k
DJTTrump Media and Technology Group Corporation
$ 36.17
(-10.87%)
3.14M
AMIXAutonomix Medical Inc
$ 1.24
(-10.14%)
892.27k
ZEOZeo Energy Corporation
$ 3.55
(-10.13%)
4.66k
KTTAPasithea Therapeutics Corporation
$ 5.51
(-9.08%)
1.94k
FFIEFaraday Future Intelligent Electric Inc
$ 0.5521
(7.16%)
8.9M
AAPLApple Inc
$ 234.92
(0.22%)
4.33M
TSLATesla Inc
$ 252.75
(0.04%)
4.18M
WNWMeiwu Technology Company Ltd
$ 1.31
(47.19%)
3.87M
MAXNMaxeon Solar Technologies Ltd
$ 0.2239
(-1.37%)
3.32M

Your Recent History

Delayed Upgrade Clock